Rhizome AI

About
What does Rhizome AI do?
Rhizome AI makes that happen. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. The data is pulled from terabytes of authoritative regulatory & clinical databases.
What is Rhizome AI's revenue?
StartupHub estimates Rhizome AI's annual revenue at $257K (range $149K to $403K, 65% confidence), based on comparable companies in the sector.
Where is Rhizome AI headquartered?
Rhizome AI is headquartered in Jersey City, NJ, United States.
When was Rhizome AI founded?
Rhizome AI was founded in 2023.
What industry does Rhizome AI operate in?
Rhizome AI operates in Biotech, AI Search Engine, Regulatory Intelligence, Clinical Data, HealthTech, Drug Discovery.
How many employees does Rhizome AI have?
Rhizome AI has approximately 3 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 2 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
